Table1 Characteristics of LUAD patients.
From: Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma
Characteristic | Levels | Overall |
|---|---|---|
n | 535 | |
Sex, n (%) | Female | 286 (53.5%) |
Male | 249 (46.5%) | |
Pathologic stage, n (%) | Stage I | 294 (55%) |
Stage II | 123 (23%) | |
Stage III | 84 (15.7%) | |
Stage IV | 26 (4.9%) | |
Unknown | 8 (1.5%) | |
M stage, n (%) | M0 | 361 (67.5%) |
M1 | 25 (4.7%) | |
MX | 143 (26.7%) | |
Unknown | 6 (1.1%) | |
N stage, n (%) | N0 | 348 (65%) |
N1 | 95 (17.8%) | |
N2 | 74 (13.8%) | |
N3 | 2 (0.4%) | |
NX | 15 (2.8%) | |
Unknown | 1 (0.2%) | |
T stage, n (%) | T1 | 175 (32.7%) |
T2 | 289 (54%) | |
T3 | 49 (9.2%) | |
T4 | 19 (3.6%) | |
TX | 3 (0.6%) | |
Age, n (%) | > 65 | 261 (48.8%) |
≤ 65 | 255 (47.7%) | |
Unknown | 19 (3.6%) |
